| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8783182 | Middle East Fertility Society Journal | 2018 | 5 Pages |
Abstract
Changes in Irisin levels may be considered as a biomarker for the detection polycystic ovarian syndrome. In the future, it may be used as a marker to follow the disease under various modalities of treatments.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ashraf A. Foda, Engy A. Foda, Ibrahim Abel-Aal,